nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—Posterior reversible encephalopathy syndrome—Vandetanib—thyroid cancer	0.0439	0.134	CcSEcCtD
Fingolimod—S1PR4—thyroid gland—thyroid cancer	0.0222	0.0798	CbGeAlD
Fingolimod—CYP4F2—trachea—thyroid cancer	0.0221	0.0794	CbGeAlD
Fingolimod—CYP4F12—saliva-secreting gland—thyroid cancer	0.0213	0.0765	CbGeAlD
Fingolimod—SPHK1—trachea—thyroid cancer	0.0171	0.0614	CbGeAlD
Fingolimod—S1PR5—head—thyroid cancer	0.0165	0.0595	CbGeAlD
Fingolimod—CYP4F12—trachea—thyroid cancer	0.0164	0.059	CbGeAlD
Fingolimod—CYP4F2—head—thyroid cancer	0.0155	0.0557	CbGeAlD
Fingolimod—S1PR3—thyroid gland—thyroid cancer	0.0155	0.0557	CbGeAlD
Fingolimod—S1PR4—lymph node—thyroid cancer	0.0138	0.0496	CbGeAlD
Fingolimod—S1PR3—head—thyroid cancer	0.0137	0.0494	CbGeAlD
Fingolimod—S1PR1—thyroid gland—thyroid cancer	0.0136	0.0491	CbGeAlD
Fingolimod—SPHK1—thyroid gland—thyroid cancer	0.0135	0.0486	CbGeAlD
Fingolimod—CYP4F12—thyroid gland—thyroid cancer	0.013	0.0467	CbGeAlD
Fingolimod—Visual acuity reduced—Vandetanib—thyroid cancer	0.0121	0.0369	CcSEcCtD
Fingolimod—S1PR1—head—thyroid cancer	0.0121	0.0436	CbGeAlD
Fingolimod—S1PR5—lymph node—thyroid cancer	0.0116	0.0416	CbGeAlD
Fingolimod—S1PR3—lymph node—thyroid cancer	0.00962	0.0346	CbGeAlD
Fingolimod—Lymphopenia—Sorafenib—thyroid cancer	0.0095	0.0289	CcSEcCtD
Fingolimod—Cerebral haemorrhage—Sorafenib—thyroid cancer	0.00878	0.0267	CcSEcCtD
Fingolimod—S1PR1—lymph node—thyroid cancer	0.00848	0.0305	CbGeAlD
Fingolimod—SPHK1—lymph node—thyroid cancer	0.00839	0.0302	CbGeAlD
Fingolimod—CYP4F12—lymph node—thyroid cancer	0.00806	0.029	CbGeAlD
Fingolimod—Gastroenteritis—Vandetanib—thyroid cancer	0.0059	0.018	CcSEcCtD
Fingolimod—Cardiac arrest—Vandetanib—thyroid cancer	0.00497	0.0152	CcSEcCtD
Fingolimod—CYP3A4—Vandetanib—thyroid cancer	0.00496	0.286	CbGbCtD
Fingolimod—CYP2D6—Sorafenib—thyroid cancer	0.0047	0.271	CbGbCtD
Fingolimod—Alanine aminotransferase increased—Vandetanib—thyroid cancer	0.00461	0.0141	CcSEcCtD
Fingolimod—Influenza—Vandetanib—thyroid cancer	0.00452	0.0138	CcSEcCtD
Fingolimod—Bronchitis—Vandetanib—thyroid cancer	0.00435	0.0132	CcSEcCtD
Fingolimod—Weight decreased—Vandetanib—thyroid cancer	0.00409	0.0125	CcSEcCtD
Fingolimod—Pneumonia—Vandetanib—thyroid cancer	0.00405	0.0124	CcSEcCtD
Fingolimod—Infestation—Vandetanib—thyroid cancer	0.00403	0.0123	CcSEcCtD
Fingolimod—Infestation NOS—Vandetanib—thyroid cancer	0.00403	0.0123	CcSEcCtD
Fingolimod—Depression—Vandetanib—thyroid cancer	0.00402	0.0122	CcSEcCtD
Fingolimod—Eczema—Sorafenib—thyroid cancer	0.00393	0.012	CcSEcCtD
Fingolimod—Sinusitis—Vandetanib—thyroid cancer	0.00378	0.0115	CcSEcCtD
Fingolimod—Bradycardia—Vandetanib—thyroid cancer	0.00368	0.0112	CcSEcCtD
Fingolimod—Lymphopenia—Epirubicin—thyroid cancer	0.00351	0.0107	CcSEcCtD
Fingolimod—Eye disorder—Vandetanib—thyroid cancer	0.00338	0.0103	CcSEcCtD
Fingolimod—Cardiac disorder—Vandetanib—thyroid cancer	0.00336	0.0102	CcSEcCtD
Fingolimod—Angiopathy—Vandetanib—thyroid cancer	0.00328	0.01	CcSEcCtD
Fingolimod—Mediastinal disorder—Vandetanib—thyroid cancer	0.00326	0.00993	CcSEcCtD
Fingolimod—Lymphopenia—Doxorubicin—thyroid cancer	0.00325	0.0099	CcSEcCtD
Fingolimod—Alopecia—Vandetanib—thyroid cancer	0.0032	0.00974	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Sorafenib—thyroid cancer	0.00318	0.00968	CcSEcCtD
Fingolimod—Mental disorder—Vandetanib—thyroid cancer	0.00317	0.00966	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Sorafenib—thyroid cancer	0.00311	0.00948	CcSEcCtD
Fingolimod—CYP3A4—Sorafenib—thyroid cancer	0.00299	0.173	CbGbCtD
Fingolimod—Vision blurred—Vandetanib—thyroid cancer	0.00297	0.00904	CcSEcCtD
Fingolimod—CYP2D6—Doxorubicin—thyroid cancer	0.00285	0.165	CbGbCtD
Fingolimod—Weight decreased—Sorafenib—thyroid cancer	0.00276	0.00841	CcSEcCtD
Fingolimod—Cough—Vandetanib—thyroid cancer	0.00275	0.00837	CcSEcCtD
Fingolimod—Pneumonia—Sorafenib—thyroid cancer	0.00273	0.00833	CcSEcCtD
Fingolimod—Hypertension—Vandetanib—thyroid cancer	0.00272	0.00828	CcSEcCtD
Fingolimod—Infestation—Sorafenib—thyroid cancer	0.00272	0.00828	CcSEcCtD
Fingolimod—Infestation NOS—Sorafenib—thyroid cancer	0.00272	0.00828	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00266	0.00811	CcSEcCtD
Fingolimod—Infection—Vandetanib—thyroid cancer	0.00255	0.00778	CcSEcCtD
Fingolimod—Nervous system disorder—Vandetanib—thyroid cancer	0.00252	0.00768	CcSEcCtD
Fingolimod—Skin disorder—Vandetanib—thyroid cancer	0.0025	0.00761	CcSEcCtD
Fingolimod—Connective tissue disorder—Sorafenib—thyroid cancer	0.0024	0.00731	CcSEcCtD
Fingolimod—Herpes zoster—Epirubicin—thyroid cancer	0.00239	0.00727	CcSEcCtD
Fingolimod—Paraesthesia—Vandetanib—thyroid cancer	0.00231	0.00703	CcSEcCtD
Fingolimod—Dyspnoea—Vandetanib—thyroid cancer	0.00229	0.00698	CcSEcCtD
Fingolimod—Cardiac disorder—Sorafenib—thyroid cancer	0.00227	0.0069	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00222	0.00676	CcSEcCtD
Fingolimod—Fatigue—Vandetanib—thyroid cancer	0.00222	0.00675	CcSEcCtD
Fingolimod—Angiopathy—Sorafenib—thyroid cancer	0.00221	0.00675	CcSEcCtD
Fingolimod—Herpes zoster—Doxorubicin—thyroid cancer	0.00221	0.00672	CcSEcCtD
Fingolimod—Mediastinal disorder—Sorafenib—thyroid cancer	0.0022	0.0067	CcSEcCtD
Fingolimod—CYP2E1—thyroid gland—thyroid cancer	0.00219	0.00787	CbGeAlD
Fingolimod—Alopecia—Sorafenib—thyroid cancer	0.00216	0.00657	CcSEcCtD
Fingolimod—Mental disorder—Sorafenib—thyroid cancer	0.00214	0.00651	CcSEcCtD
Fingolimod—Liver injury—Epirubicin—thyroid cancer	0.00213	0.0065	CcSEcCtD
Fingolimod—Liver injury—Doxorubicin—thyroid cancer	0.00198	0.00602	CcSEcCtD
Fingolimod—CYP2E1—head—thyroid cancer	0.00194	0.00698	CbGeAlD
Fingolimod—Leukopenia—Sorafenib—thyroid cancer	0.0019	0.00579	CcSEcCtD
Fingolimod—Cough—Sorafenib—thyroid cancer	0.00185	0.00565	CcSEcCtD
Fingolimod—Atrioventricular block—Epirubicin—thyroid cancer	0.00185	0.00564	CcSEcCtD
Fingolimod—Asthenia—Vandetanib—thyroid cancer	0.00184	0.00562	CcSEcCtD
Fingolimod—Hypertension—Sorafenib—thyroid cancer	0.00183	0.00559	CcSEcCtD
Fingolimod—Pruritus—Vandetanib—thyroid cancer	0.00182	0.00554	CcSEcCtD
Fingolimod—CYP3A4—Doxorubicin—thyroid cancer	0.00181	0.105	CbGbCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.0018	0.00547	CcSEcCtD
Fingolimod—Diarrhoea—Vandetanib—thyroid cancer	0.00176	0.00536	CcSEcCtD
Fingolimod—Infection—Sorafenib—thyroid cancer	0.00172	0.00525	CcSEcCtD
Fingolimod—Atrioventricular block—Doxorubicin—thyroid cancer	0.00171	0.00522	CcSEcCtD
Fingolimod—Nervous system disorder—Sorafenib—thyroid cancer	0.0017	0.00518	CcSEcCtD
Fingolimod—Dizziness—Vandetanib—thyroid cancer	0.0017	0.00518	CcSEcCtD
Fingolimod—Skin disorder—Sorafenib—thyroid cancer	0.00168	0.00513	CcSEcCtD
Fingolimod—Headache—Vandetanib—thyroid cancer	0.00161	0.00491	CcSEcCtD
Fingolimod—Dyspnoea—Sorafenib—thyroid cancer	0.00155	0.00471	CcSEcCtD
Fingolimod—CYP2D6—head—thyroid cancer	0.00154	0.00553	CbGeAlD
Fingolimod—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.0015	0.00456	CcSEcCtD
Fingolimod—Fatigue—Sorafenib—thyroid cancer	0.0015	0.00455	CcSEcCtD
Fingolimod—Eczema—Epirubicin—thyroid cancer	0.00145	0.00442	CcSEcCtD
Fingolimod—Eye pain—Epirubicin—thyroid cancer	0.00144	0.0044	CcSEcCtD
Fingolimod—Eczema—Doxorubicin—thyroid cancer	0.00134	0.00409	CcSEcCtD
Fingolimod—Eye pain—Doxorubicin—thyroid cancer	0.00134	0.00407	CcSEcCtD
Fingolimod—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00133	0.00405	CcSEcCtD
Fingolimod—Migraine—Epirubicin—thyroid cancer	0.00128	0.00391	CcSEcCtD
Fingolimod—Asthenia—Sorafenib—thyroid cancer	0.00124	0.00379	CcSEcCtD
Fingolimod—Cardiac arrest—Epirubicin—thyroid cancer	0.00124	0.00378	CcSEcCtD
Fingolimod—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00123	0.00375	CcSEcCtD
Fingolimod—Pruritus—Sorafenib—thyroid cancer	0.00123	0.00374	CcSEcCtD
Fingolimod—Liver function test abnormal—Epirubicin—thyroid cancer	0.0012	0.00367	CcSEcCtD
Fingolimod—Migraine—Doxorubicin—thyroid cancer	0.00119	0.00362	CcSEcCtD
Fingolimod—Diarrhoea—Sorafenib—thyroid cancer	0.00119	0.00361	CcSEcCtD
Fingolimod—SPHK1—Signaling by VEGF—NRAS—thyroid cancer	0.00118	0.00313	CbGpPWpGaD
Fingolimod—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00117	0.00358	CcSEcCtD
Fingolimod—S1PR5—GPCR downstream signaling—TSHR—thyroid cancer	0.00117	0.00309	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—TSHR—thyroid cancer	0.00117	0.00309	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TRIM33—thyroid cancer	0.00116	0.00309	CbGpPWpGaD
Fingolimod—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00115	0.0035	CcSEcCtD
Fingolimod—Cardiac arrest—Doxorubicin—thyroid cancer	0.00115	0.0035	CcSEcCtD
Fingolimod—Dizziness—Sorafenib—thyroid cancer	0.00115	0.00349	CcSEcCtD
Fingolimod—Influenza—Epirubicin—thyroid cancer	0.00113	0.00343	CcSEcCtD
Fingolimod—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00111	0.00339	CcSEcCtD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—NRAS—thyroid cancer	0.0011	0.00293	CbGpPWpGaD
Fingolimod—CYP2E1—Vitamin A and Carotenoid Metabolism—RXRA—thyroid cancer	0.0011	0.00292	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—TSHR—thyroid cancer	0.0011	0.00292	CbGpPWpGaD
Fingolimod—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.00109	0.00331	CcSEcCtD
Fingolimod—Headache—Sorafenib—thyroid cancer	0.00109	0.00331	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—CALCB—thyroid cancer	0.00109	0.00288	CbGpPWpGaD
Fingolimod—Bronchitis—Epirubicin—thyroid cancer	0.00108	0.0033	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—PRKAR1A—thyroid cancer	0.00108	0.00287	CbGpPWpGaD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—KRAS—thyroid cancer	0.00107	0.00285	CbGpPWpGaD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—KRAS—thyroid cancer	0.00107	0.00285	CbGpPWpGaD
Fingolimod—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.00106	0.00324	CcSEcCtD
Fingolimod—S1PR5—Signaling by GPCR—TSHR—thyroid cancer	0.00106	0.00281	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—TSHR—thyroid cancer	0.00106	0.00281	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—TSHR—thyroid cancer	0.00106	0.00281	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—HPGD—thyroid cancer	0.00105	0.00278	CbGpPWpGaD
Fingolimod—Influenza—Doxorubicin—thyroid cancer	0.00104	0.00318	CcSEcCtD
Fingolimod—S1PR3—Signaling by GPCR—PRKAR1A—thyroid cancer	0.00104	0.00276	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—PRKAR1A—thyroid cancer	0.00104	0.00276	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TRIM33—thyroid cancer	0.00103	0.00273	CbGpPWpGaD
Fingolimod—Weight decreased—Epirubicin—thyroid cancer	0.00102	0.00311	CcSEcCtD
Fingolimod—SPHK1—Signaling by VEGF—KRAS—thyroid cancer	0.00101	0.00269	CbGpPWpGaD
Fingolimod—Pneumonia—Epirubicin—thyroid cancer	0.00101	0.00308	CcSEcCtD
Fingolimod—Infestation NOS—Epirubicin—thyroid cancer	0.001	0.00306	CcSEcCtD
Fingolimod—Infestation—Epirubicin—thyroid cancer	0.001	0.00306	CcSEcCtD
Fingolimod—Bronchitis—Doxorubicin—thyroid cancer	0.001	0.00306	CcSEcCtD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000988	0.00262	CbGpPWpGaD
Fingolimod—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000981	0.0026	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—TSHR—thyroid cancer	0.000961	0.00255	CbGpPWpGaD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—KRAS—thyroid cancer	0.000949	0.00252	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000945	0.00251	CbGpPWpGaD
Fingolimod—Weight decreased—Doxorubicin—thyroid cancer	0.000943	0.00287	CcSEcCtD
Fingolimod—Sinusitis—Epirubicin—thyroid cancer	0.000943	0.00287	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—SST—thyroid cancer	0.000941	0.0025	CbGpPWpGaD
Fingolimod—Pneumonia—Doxorubicin—thyroid cancer	0.000935	0.00285	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—PTCH1—thyroid cancer	0.000935	0.00248	CbGpPWpGaD
Fingolimod—Infestation NOS—Doxorubicin—thyroid cancer	0.00093	0.00283	CcSEcCtD
Fingolimod—Infestation—Doxorubicin—thyroid cancer	0.00093	0.00283	CcSEcCtD
Fingolimod—Bradycardia—Epirubicin—thyroid cancer	0.000918	0.0028	CcSEcCtD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—HRAS—thyroid cancer	0.000913	0.00243	CbGpPWpGaD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—HRAS—thyroid cancer	0.000911	0.00242	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—CALCA—thyroid cancer	0.000906	0.00241	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—SST—thyroid cancer	0.000906	0.00241	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—SST—thyroid cancer	0.000906	0.00241	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—PTCH1—thyroid cancer	0.0009	0.00239	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—PTCH1—thyroid cancer	0.0009	0.00239	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TCF7L1—thyroid cancer	0.000887	0.00236	CbGpPWpGaD
Fingolimod—Connective tissue disorder—Epirubicin—thyroid cancer	0.000886	0.0027	CcSEcCtD
Fingolimod—Sinusitis—Doxorubicin—thyroid cancer	0.000872	0.00266	CcSEcCtD
Fingolimod—S1PR3—GPCR downstream signaling—CALCA—thyroid cancer	0.000872	0.00232	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—CALCA—thyroid cancer	0.000872	0.00232	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—CHST14—thyroid cancer	0.000872	0.00232	CbGpPWpGaD
Fingolimod—SPHK1—Signaling by VEGF—HRAS—thyroid cancer	0.000862	0.00229	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—SST—thyroid cancer	0.000855	0.00227	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TCF7L1—thyroid cancer	0.000854	0.00227	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TCF7L1—thyroid cancer	0.000854	0.00227	CbGpPWpGaD
Fingolimod—Bradycardia—Doxorubicin—thyroid cancer	0.00085	0.00259	CcSEcCtD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000848	0.00225	CbGpPWpGaD
Fingolimod—Eye disorder—Epirubicin—thyroid cancer	0.000843	0.00257	CcSEcCtD
Fingolimod—CYP2E1—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000842	0.00224	CbGpPWpGaD
Fingolimod—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000838	0.00223	CbGpPWpGaD
Fingolimod—Cardiac disorder—Epirubicin—thyroid cancer	0.000837	0.00255	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—CALCA—thyroid cancer	0.000823	0.00219	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—SST—thyroid cancer	0.000823	0.00219	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—SST—thyroid cancer	0.000823	0.00219	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—SST—thyroid cancer	0.000823	0.00219	CbGpPWpGaD
Fingolimod—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00082	0.0025	CcSEcCtD
Fingolimod—Angiopathy—Epirubicin—thyroid cancer	0.000818	0.00249	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—PTCH1—thyroid cancer	0.000817	0.00217	CbGpPWpGaD
Fingolimod—Mediastinal disorder—Epirubicin—thyroid cancer	0.000813	0.00248	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—TPR—thyroid cancer	0.00081	0.00215	CbGpPWpGaD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—HRAS—thyroid cancer	0.000806	0.00214	CbGpPWpGaD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—AKT1—thyroid cancer	0.000806	0.00214	CbGpPWpGaD
Fingolimod—Alopecia—Epirubicin—thyroid cancer	0.000797	0.00243	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—PRKAR1A—thyroid cancer	0.000797	0.00212	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CALCA—thyroid cancer	0.000792	0.0021	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CALCA—thyroid cancer	0.000792	0.0021	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CALCA—thyroid cancer	0.000792	0.0021	CbGpPWpGaD
Fingolimod—Mental disorder—Epirubicin—thyroid cancer	0.00079	0.00241	CcSEcCtD
Fingolimod—Eye disorder—Doxorubicin—thyroid cancer	0.00078	0.00238	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—TCF7L1—thyroid cancer	0.000775	0.00206	CbGpPWpGaD
Fingolimod—Cardiac disorder—Doxorubicin—thyroid cancer	0.000775	0.00236	CcSEcCtD
Fingolimod—SPHK1—Signaling by VEGF—AKT1—thyroid cancer	0.000761	0.00202	CbGpPWpGaD
Fingolimod—Back pain—Epirubicin—thyroid cancer	0.00076	0.00231	CcSEcCtD
Fingolimod—Angiopathy—Doxorubicin—thyroid cancer	0.000757	0.00231	CcSEcCtD
Fingolimod—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000752	0.00229	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—SST—thyroid cancer	0.000747	0.00198	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CDK1—thyroid cancer	0.000745	0.00198	CbGpPWpGaD
Fingolimod—Vision blurred—Epirubicin—thyroid cancer	0.00074	0.00225	CcSEcCtD
Fingolimod—Alopecia—Doxorubicin—thyroid cancer	0.000738	0.00225	CcSEcCtD
Fingolimod—Mental disorder—Doxorubicin—thyroid cancer	0.000731	0.00223	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—CALCA—thyroid cancer	0.000719	0.00191	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CDK1—thyroid cancer	0.000717	0.0019	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CDK1—thyroid cancer	0.000717	0.0019	CbGpPWpGaD
Fingolimod—Leukopenia—Epirubicin—thyroid cancer	0.000703	0.00214	CcSEcCtD
Fingolimod—Back pain—Doxorubicin—thyroid cancer	0.000703	0.00214	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—TPR—thyroid cancer	0.000699	0.00186	CbGpPWpGaD
Fingolimod—Palpitations—Epirubicin—thyroid cancer	0.000694	0.00211	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—PRKAR1A—thyroid cancer	0.000688	0.00183	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TCF7L1—thyroid cancer	0.000686	0.00182	CbGpPWpGaD
Fingolimod—Cough—Epirubicin—thyroid cancer	0.000685	0.00209	CcSEcCtD
Fingolimod—Vision blurred—Doxorubicin—thyroid cancer	0.000685	0.00209	CcSEcCtD
Fingolimod—CYP2E1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000683	0.00181	CbGpPWpGaD
Fingolimod—Hypertension—Epirubicin—thyroid cancer	0.000678	0.00207	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000664	0.00202	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—CDK1—thyroid cancer	0.000651	0.00173	CbGpPWpGaD
Fingolimod—Leukopenia—Doxorubicin—thyroid cancer	0.00065	0.00198	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—TSHR—thyroid cancer	0.000649	0.00172	CbGpPWpGaD
Fingolimod—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000646	0.00172	CbGpPWpGaD
Fingolimod—Palpitations—Doxorubicin—thyroid cancer	0.000642	0.00196	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—PRKAR1A—thyroid cancer	0.000639	0.0017	CbGpPWpGaD
Fingolimod—Infection—Epirubicin—thyroid cancer	0.000637	0.00194	CcSEcCtD
Fingolimod—Cough—Doxorubicin—thyroid cancer	0.000634	0.00193	CcSEcCtD
Fingolimod—Nervous system disorder—Epirubicin—thyroid cancer	0.000629	0.00191	CcSEcCtD
Fingolimod—Hypertension—Doxorubicin—thyroid cancer	0.000627	0.00191	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—TSHR—thyroid cancer	0.000625	0.00166	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TSHR—thyroid cancer	0.000625	0.00166	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000624	0.00166	CbGpPWpGaD
Fingolimod—Skin disorder—Epirubicin—thyroid cancer	0.000623	0.0019	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—PRKAR1A—thyroid cancer	0.000615	0.00163	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PRKAR1A—thyroid cancer	0.000615	0.00163	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000614	0.00187	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—MEN1—thyroid cancer	0.000611	0.00162	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—SLC5A5—thyroid cancer	0.000606	0.00161	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—TPR—thyroid cancer	0.000601	0.0016	CbGpPWpGaD
Fingolimod—Hypotension—Epirubicin—thyroid cancer	0.000599	0.00182	CcSEcCtD
Fingolimod—CYP2D6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000598	0.00159	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PRKAR1A—thyroid cancer	0.000591	0.00157	CbGpPWpGaD
Fingolimod—Infection—Doxorubicin—thyroid cancer	0.000589	0.00179	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—MEN1—thyroid cancer	0.000588	0.00156	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MEN1—thyroid cancer	0.000588	0.00156	CbGpPWpGaD
Fingolimod—Nervous system disorder—Doxorubicin—thyroid cancer	0.000582	0.00177	CcSEcCtD
Fingolimod—Skin disorder—Doxorubicin—thyroid cancer	0.000576	0.00175	CcSEcCtD
Fingolimod—Paraesthesia—Epirubicin—thyroid cancer	0.000575	0.00175	CcSEcCtD
Fingolimod—Dyspnoea—Epirubicin—thyroid cancer	0.000571	0.00174	CcSEcCtD
Fingolimod—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.00057	0.00151	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TSHR—thyroid cancer	0.000568	0.00151	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PRKAR1A—thyroid cancer	0.000558	0.00148	CbGpPWpGaD
Fingolimod—Hypotension—Doxorubicin—thyroid cancer	0.000554	0.00169	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000553	0.00169	CcSEcCtD
Fingolimod—Fatigue—Epirubicin—thyroid cancer	0.000553	0.00168	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—PTCH1—thyroid cancer	0.000552	0.00147	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000536	0.00142	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MEN1—thyroid cancer	0.000534	0.00142	CbGpPWpGaD
Fingolimod—Paraesthesia—Doxorubicin—thyroid cancer	0.000532	0.00162	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—PTCH1—thyroid cancer	0.000531	0.00141	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PTCH1—thyroid cancer	0.000531	0.00141	CbGpPWpGaD
Fingolimod—Dyspnoea—Doxorubicin—thyroid cancer	0.000529	0.00161	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—SLC5A5—thyroid cancer	0.000523	0.00139	CbGpPWpGaD
Fingolimod—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000512	0.00156	CcSEcCtD
Fingolimod—Fatigue—Doxorubicin—thyroid cancer	0.000511	0.00156	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—RXRA—thyroid cancer	0.000509	0.00135	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SST—thyroid cancer	0.000505	0.00134	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TSHR—thyroid cancer	0.000502	0.00133	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PRKAR1A—thyroid cancer	0.000494	0.00131	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.00049	0.0013	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CALCA—thyroid cancer	0.000486	0.00129	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SST—thyroid cancer	0.000486	0.00129	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SST—thyroid cancer	0.000486	0.00129	CbGpPWpGaD
Fingolimod—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000485	0.00129	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PTCH1—thyroid cancer	0.000483	0.00128	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MEN1—thyroid cancer	0.000472	0.00125	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CALCA—thyroid cancer	0.000468	0.00124	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CALCA—thyroid cancer	0.000468	0.00124	CbGpPWpGaD
Fingolimod—Asthenia—Epirubicin—thyroid cancer	0.00046	0.0014	CcSEcCtD
Fingolimod—Pruritus—Epirubicin—thyroid cancer	0.000453	0.00138	CcSEcCtD
Fingolimod—SPHK1—Metabolism—SLC5A5—thyroid cancer	0.00045	0.00119	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SST—thyroid cancer	0.000441	0.00117	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CDK1—thyroid cancer	0.00044	0.00117	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—RXRA—thyroid cancer	0.00044	0.00117	CbGpPWpGaD
Fingolimod—Diarrhoea—Epirubicin—thyroid cancer	0.000439	0.00134	CcSEcCtD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000428	0.00114	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PTCH1—thyroid cancer	0.000427	0.00113	CbGpPWpGaD
Fingolimod—Asthenia—Doxorubicin—thyroid cancer	0.000425	0.0013	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—CALCA—thyroid cancer	0.000425	0.00113	CbGpPWpGaD
Fingolimod—Dizziness—Epirubicin—thyroid cancer	0.000424	0.00129	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—CDK1—thyroid cancer	0.000424	0.00112	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CDK1—thyroid cancer	0.000424	0.00112	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000421	0.00112	CbGpPWpGaD
Fingolimod—Pruritus—Doxorubicin—thyroid cancer	0.00042	0.00128	CcSEcCtD
Fingolimod—Diarrhoea—Doxorubicin—thyroid cancer	0.000406	0.00124	CcSEcCtD
Fingolimod—Headache—Epirubicin—thyroid cancer	0.000402	0.00122	CcSEcCtD
Fingolimod—Dizziness—Doxorubicin—thyroid cancer	0.000392	0.00119	CcSEcCtD
Fingolimod—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000391	0.00104	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SST—thyroid cancer	0.000391	0.00104	CbGpPWpGaD
Fingolimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000389	0.00103	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CDK1—thyroid cancer	0.000385	0.00102	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—RXRA—thyroid cancer	0.000378	0.001	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CALCA—thyroid cancer	0.000376	0.000999	CbGpPWpGaD
Fingolimod—Headache—Doxorubicin—thyroid cancer	0.000372	0.00113	CcSEcCtD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000368	0.000976	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—RXRA—thyroid cancer	0.000363	0.000963	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NRG1—thyroid cancer	0.000353	0.000938	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CDK1—thyroid cancer	0.00034	0.000904	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NRG1—thyroid cancer	0.00034	0.000903	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NRG1—thyroid cancer	0.00034	0.000903	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PPARG—thyroid cancer	0.000322	0.000854	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TERT—thyroid cancer	0.000317	0.000842	CbGpPWpGaD
Fingolimod—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000317	0.000841	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NRG1—thyroid cancer	0.000309	0.00082	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TERT—thyroid cancer	0.000305	0.000811	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TERT—thyroid cancer	0.000305	0.000811	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HIF1A—thyroid cancer	0.000303	0.000806	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HIF1A—thyroid cancer	0.000292	0.000775	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HIF1A—thyroid cancer	0.000292	0.000775	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PPARG—thyroid cancer	0.000278	0.000738	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TERT—thyroid cancer	0.000277	0.000736	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NRG1—thyroid cancer	0.000273	0.000726	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—NRAS—thyroid cancer	0.000267	0.00071	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MINPP1—thyroid cancer	0.000266	0.000708	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HIF1A—thyroid cancer	0.000265	0.000704	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—RXRA—thyroid cancer	0.000257	0.000684	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—NRAS—thyroid cancer	0.000257	0.000683	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—NRAS—thyroid cancer	0.000257	0.000683	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PTGS2—thyroid cancer	0.000253	0.000672	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—BRAF—thyroid cancer	0.000251	0.000667	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TERT—thyroid cancer	0.000245	0.000652	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—BRAF—thyroid cancer	0.000242	0.000642	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—BRAF—thyroid cancer	0.000242	0.000642	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PPARG—thyroid cancer	0.000239	0.000634	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HIF1A—thyroid cancer	0.000235	0.000623	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—NRAS—thyroid cancer	0.000234	0.00062	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—KRAS—thyroid cancer	0.00023	0.000611	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NDUFA13—thyroid cancer	0.000227	0.000602	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—KRAS—thyroid cancer	0.000221	0.000588	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—KRAS—thyroid cancer	0.000221	0.000588	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PTEN—thyroid cancer	0.000221	0.000586	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—BRAF—thyroid cancer	0.00022	0.000583	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PTGS2—thyroid cancer	0.000218	0.00058	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CHST14—thyroid cancer	0.000213	0.000566	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—KRAS—thyroid cancer	0.000201	0.000534	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—HRAS—thyroid cancer	0.000195	0.000519	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—BRAF—thyroid cancer	0.000194	0.000516	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PTEN—thyroid cancer	0.00019	0.000506	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—AKT1—thyroid cancer	0.00019	0.000505	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MINPP1—thyroid cancer	0.000189	0.000502	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—HRAS—thyroid cancer	0.000188	0.0005	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—HRAS—thyroid cancer	0.000188	0.0005	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTGS2—thyroid cancer	0.000188	0.000498	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCND1—thyroid cancer	0.000183	0.000487	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—AKT1—thyroid cancer	0.000183	0.000486	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—AKT1—thyroid cancer	0.000183	0.000486	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PTEN—thyroid cancer	0.000177	0.00047	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCND1—thyroid cancer	0.000176	0.000469	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCND1—thyroid cancer	0.000176	0.000469	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—AKT1—thyroid cancer	0.000173	0.000458	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HPGD—thyroid cancer	0.000172	0.000456	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—HRAS—thyroid cancer	0.000171	0.000454	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PTEN—thyroid cancer	0.00017	0.000452	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PTEN—thyroid cancer	0.00017	0.000452	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—RXRA—thyroid cancer	0.000168	0.000447	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—AKT1—thyroid cancer	0.000166	0.000441	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—AKT1—thyroid cancer	0.000166	0.000441	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—AKT1—thyroid cancer	0.000166	0.000441	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTEN—thyroid cancer	0.000164	0.000435	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NDUFA13—thyroid cancer	0.000161	0.000427	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCND1—thyroid cancer	0.00016	0.000426	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NRAS—thyroid cancer	0.000158	0.000419	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PTEN—thyroid cancer	0.000155	0.000411	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NRAS—thyroid cancer	0.000152	0.000404	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NRAS—thyroid cancer	0.000152	0.000404	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CHST14—thyroid cancer	0.000151	0.000402	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—AKT1—thyroid cancer	0.000151	0.000401	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCND1—thyroid cancer	0.000142	0.000377	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NRAS—thyroid cancer	0.000138	0.000366	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PTEN—thyroid cancer	0.000137	0.000363	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—KRAS—thyroid cancer	0.000136	0.000361	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—KRAS—thyroid cancer	0.000131	0.000347	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—KRAS—thyroid cancer	0.000131	0.000347	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—AKT1—thyroid cancer	0.000127	0.000338	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MINPP1—thyroid cancer	0.000124	0.000328	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NRAS—thyroid cancer	0.000122	0.000324	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HPGD—thyroid cancer	0.000122	0.000324	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TP53—thyroid cancer	0.000121	0.000321	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—KRAS—thyroid cancer	0.000119	0.000315	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—thyroid cancer	0.000116	0.000309	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—thyroid cancer	0.000116	0.000309	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HRAS—thyroid cancer	0.000115	0.000307	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HRAS—thyroid cancer	0.000111	0.000295	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HRAS—thyroid cancer	0.000111	0.000295	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—AKT1—thyroid cancer	0.00011	0.000292	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—thyroid cancer	0.000106	0.00028	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NDUFA13—thyroid cancer	0.000105	0.000279	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KRAS—thyroid cancer	0.000105	0.000279	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—AKT1—thyroid cancer	0.000102	0.000271	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HRAS—thyroid cancer	0.000101	0.000268	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CHST14—thyroid cancer	9.88e-05	0.000263	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TPR—thyroid cancer	9.86e-05	0.000262	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—AKT1—thyroid cancer	9.81e-05	0.000261	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—AKT1—thyroid cancer	9.81e-05	0.000261	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	9.7e-05	0.000258	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—AKT1—thyroid cancer	9.43e-05	0.000251	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—thyroid cancer	9.34e-05	0.000248	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HRAS—thyroid cancer	8.93e-05	0.000237	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—AKT1—thyroid cancer	8.91e-05	0.000237	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HPGD—thyroid cancer	7.97e-05	0.000212	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—AKT1—thyroid cancer	7.89e-05	0.000209	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC5A5—thyroid cancer	7.38e-05	0.000196	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TPR—thyroid cancer	7e-05	0.000186	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	6.89e-05	0.000183	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—RXRA—thyroid cancer	6.2e-05	0.000165	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC5A5—thyroid cancer	5.24e-05	0.000139	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TPR—thyroid cancer	4.58e-05	0.000122	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	4.5e-05	0.00012	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—RXRA—thyroid cancer	4.4e-05	0.000117	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPARG—thyroid cancer	3.92e-05	0.000104	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC5A5—thyroid cancer	3.43e-05	9.1e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS2—thyroid cancer	3.08e-05	8.18e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—RXRA—thyroid cancer	2.88e-05	7.64e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPARG—thyroid cancer	2.78e-05	7.38e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTEN—thyroid cancer	2.69e-05	7.14e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS2—thyroid cancer	2.19e-05	5.81e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTEN—thyroid cancer	1.91e-05	5.06e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPARG—thyroid cancer	1.82e-05	4.83e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AKT1—thyroid cancer	1.55e-05	4.11e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS2—thyroid cancer	1.43e-05	3.8e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTEN—thyroid cancer	1.25e-05	3.31e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AKT1—thyroid cancer	1.1e-05	2.92e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AKT1—thyroid cancer	7.18e-06	1.91e-05	CbGpPWpGaD
